Continuing medical education

Specialty CME Series: The Time to Act is Now - Understanding and Addressing Health Disparities in Cancer Care (LIVE Webcast)

Despite disparities in health care quality, outcomes, complications, excess disease burden, and premature death rates in cancer (in addition to a many other illnesses) being well documented, little progress has been done in reducing them. Even when physicians and health professionals are aware of such disparities, they may be unaware the effect on their own patients and what they can do to help to address such disparities.

In a 3-part series, CTCA leaders Anita Johnson and Chevon Rariy join other leaders in the medical arena to discuss the health disparities within cancer care, uncover some of the hurdles to providing better care, and expound on how health systems, communities, and larger healthcare ecosystem can empower patients, providers, payors, and others to build trust, provide access, and discuss evidence-based practices and strategies to help reduce disparities in health care and advance health equity in cancer care.

After participating in this 3-part series, learners will be able to:

• Describe the current state of racial disparities in cancer and cancer care in the US
• Discuss the racial disparities in breast cancer
• Discuss the racial disparities in prostate cancer
• Describe strategies to reduce disparities in cancer care and promote health equity

Co-Chairs:

• Anita Johnson, MD, FACS (Cancer Treatment Centers of America)
• Chevon Rariy, MD (Cancer Treatment Centers of America)

Faculty:

Part 1:

• Ebbin Dotson, PhD, MHSA (School of Public Health, University of Michigan)
• Jonathan Watkins, MPA, FACHE (Cancer Treatment Centers of America)
• Christa-Marie Singleton, MD, MPH (Centers for Disease Control and Prevention)

Part 2:

• Lauren McCullough, PhD, MSPH (Rollins School of Public Health, Emory University)
• Brian Rivers, PhD, MPH (Morehouse School of Medicine)
• Altovise Ewing, PhD, LCGC (Genetech)

Part 3:

• John Horrigan, PhD (Technology Policy Institute)
• Vernessa Pollard, Esq. (McDermott Will & Emery)
• Tracy Wiedt, MPH (American Cancer Society)
• Kimberly Noel, MD (Stony Brook University)

Specialty CME Series: COVID-19 and Hematologic Disturbances (LIVE Webcast)

The Specialty CME Series is designed to provide oncologists, primary care providers or other specialists with the latest information, data, best practices, recommendations and guidelines for treating cancer patients. In this episode of the series, Syed A. Abutalib, MD, will discuss the management of patients with COVID-19 infections and hematologic disturbances.

After participating in this education, learners will be able to:

• Discuss the management of patients with COVID-19 and hematologic malignancies

Faculty:

• Syed A. Abutalib, MD (Cancer Treatment Centers of America)

CME Forum 2020: 5th Annual Advancements in Cancer Management

CME Forum is an educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Recordings of presentations, case studies and Q & A sessions are available on demand or as live webinars to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each on demand event.

Molecular Tumor Board Series 2020

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic/genomic testing, pathology and radiological imaging. Cases discussed include: gallbladder carcinoma, triple negative breast cancer, endometrial cancer and adenocarcinoma of unknown primary.

Upon completion of this activity, participants will be able to:

• Describe the necessary components of an effective molecular tumor board
• Explain how to integrate genomic profiling into oncology treatment plans

Faculty:

• Jason Beland, MD (Cancer Treatment Centers of America)
• Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Kimberly McGregor, MD (Foundation Medicine)
• Ankur Parikh, DO (Cancer Treatment Centers of America)
• Patricia Rich, MD (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Bradford Tan, MD (Cancer Treatment Centers of America)

Multidisciplinary Management of Rectal Cancer in Young Adults: Facts and Controversies

This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.

Upon completion of this activity, participants will be able to:

• Explain the different approaches for managing rectal cancer in young adults
• Identify the appropriate approach for the treatment of rectal cancer in young adults

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD, FACP (Banner MD Anderson)
• David Etzioni, MS, MD (Mayo Clinic – Phoenix)

Rapidly Scaling Oncology Telehealth Services

COVID-19 changed the landscape for many healthcare providers. In addition to creating a need for appointments with minimal contact, the Centers for Medicare and Medicaid relaxed and modified policy surrounding telehealth appointments to facilitate quick transition to virtual appointments. This education will share best practices and compliance considerations for deploying a pandemic response telehealth program, and recommendations for transitioning this program to a post-COVID world.

Upon completion of this activity, participants will be able to:

• Describe key practices and necessary system infrastructure for successful implementation of a telehealth program
• Discuss the importance of a targeted focus for a telehealth program in response to COVID-19
• Discuss the technological and legal considerations when launching a telehealth program
• Develop targeted telehealth programs and identify specific appointment types that can be appropriately addressed via telehealth appointments

Faculty:

• Jennifer Greenman, MBA (Cancer Treatment Centers of America)
• Gillian Leene, Esq. (Cancer Treatment Centers of America)
• Chevon Rariy, MD (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Jennifer Smith, MBA (Cancer Treatment Centers of America)

Lymphedema Management and Surgical Therapy

Lymphedema is a common side effect in patients with cancer. While surgical interventions may sometimes be necessary, there are many less invasive options as well which may effectively manage the condition for some patients. This program aims to discuss the latest data on methods of managing lymphedema, and how to determine which method is best for each patient.

Upon completion of this activity, participants will be able to:

• Describe the various techniques for treating lymphedema in patients with cancer
• Apply the appropriate method of lymphedema management to a specific patient

Faculty:

• Daniel Liu, MD (Cancer Treatment Centers of America)

Lung Nodules: Evaluation and Diagnostic Approaches

Clinicians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.

Upon completion of this activity, participants will be able to:

• Discuss the various diagnostic and staging procedures for lung nodules
• Select the appropriate approach and follow-up for high-risk patients with lung nodules

Faculty:

• Abdul Hamid Alraiyes, MD, FCCP (Cancer Treatment Centers of America)